Core Laboratories N.V. (CLB)
$
11.74
-0.06 (-0.51%)
Key metrics
Financial statements
Free cash flow per share
0.9386
Market cap
550.4 Million
Price to sales ratio
1.0630
Debt to equity
0.7104
Current ratio
2.2055
Income quality
2.0282
Average inventory
59.2 Million
ROE
0.1119
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The weighted average number of diluted shares outstanding is 47,685,000.00 reflecting potential dilution effects. The company incurred an income tax expense of $14,034,000.00 indicating its tax obligations. The cost of revenue for the company is $435,475,000.00 showcasing its production and operational expenses. The company reported an income before tax of $45,951,000.00 showcasing its pre-tax profitability. Furthermore, the weighted average number of shares outstanding is 46,897,000.00 highlighting the company's shareholder base. Core Laboratories N.V. provides essential reservoir description and production enhancement services and products to the oil and gas industry across the United States, Canada, and internationally. Operating through its Reservoir Description and Production Enhancement segments, the company specializes in characterizing petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery from its clients' reservoirs. The Reservoir Description segment offers laboratory-based analytical and field services, including proprietary and joint industry studies, to assess crude oil properties and improve product delivery. In contrast, the Production Enhancement segment focuses on well completions, perforations, stimulations, and production-related services, providing integrated diagnostic services to evaluate and enhance the effectiveness of enhanced oil recovery projects. Additionally, the company markets its products through sales representatives, trade shows, and print advertising, extending its reach through distributors in approximately 50 countries. Founded in 1936 and based in Amstelveen, the Netherlands, Core Laboratories remains a pivotal player in the oil and gas landscape. The stock is affordable at $11.74 suitable for budget-conscious investors. However, the stock has a low average trading volume of 552,059.00 indicating lower market activity. With a market capitalization of $550,405,246.00 the company is classified as a small-cap player. It is a key player in the Oil & Gas Equipment & Services industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Energy sector, driving innovation and growth. Through its dedicated services and extensive market presence, Core Laboratories continues to address the needs of its clients and influence the energy sector's future.
Investing in Core Laboratories N.V. (CLB) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Core Laboratories N.V. stock to fluctuate between $10.14 (low) and $25.13 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-06-27, Core Laboratories N.V.'s market cap is $550,405,246, based on 46,882,900 outstanding shares.
Compared to Exxon Mobil Corporation, Core Laboratories N.V. has a Lower Market-Cap, indicating a difference in performance.
Core Laboratories N.V. pays dividends. The current dividend yield is 0.33%, with a payout of $0.01 per share.
To buy Core Laboratories N.V. (CLB) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CLB. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Core Laboratories N.V.'s last stock split was 2:1 on 2010-07-09.
Revenue: $523,848,000 | EPS: $0.67 | Growth: -15.19%.
Visit https://www.corelab.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $49.87 (2021-06-11) | All-time low: $10.14 (2025-04-09).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
zacks.com
CLB struggles with a 4.4% revenue decline, low ROIC in the first quarter of 2025, minimal dividends and vulnerability to oil price volatility and geopolitical instability.
seekingalpha.com
Core Laboratories Inc. (NYSE:CLB ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Sean Mitchell - Daniel Energy Partners Operator Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
zacks.com
Core Laboratories (CLB) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago.
zacks.com
CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief.
zacks.com
CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution.
zacks.com
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
zacks.com
Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.
seekingalpha.com
Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Josh Jayne - Daniel Energy Partners David Smith - Pickering Energy Partners Operator Good day, and welcome to the Core Laboratories' Fourth Quarter 2024 Earnings Call. All participants will be in listen-only mode.
zacks.com
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.19 per share a year ago.
See all news